Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $10.1 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 47.42.
Market Cap
10.1T
Revenue
4.74T
Profits
212.97B
PE Ratio
47.42
Profit Margin
4.49%
Dividend Yield
0.37%
1049 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | 4.28% | 4,033,896 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 679.13B | 2.13% | 6,904,436 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 518.44B | 0.68% | 5,867,057 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 366.73B | 1.38% | 7,565,866 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 356.28B | 0.88% | 4,885,971 | 450.06B |
| 6 | NVS | Novartis AG | 306.88B | 0.70% | 2,317,792 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 292.66B | 1.59% | 2,426,072 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 267.38B | 3.87% | 2,274,789 | 47.35B |
| 9 | AMGN | Amgen Inc. | 251.65B | 1.04% | 2,311,465 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 210.01B | 1.46% | 4,471,996 | 30.99B |
| 11 | ABT | Abbott Laboratories | 191.40B | 0.53% | 7,838,055 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 180.26B | 2.65% | 11,761,217 | 50.70B |
| 13 | PFE | Pfizer Inc. | 166.61B | -0.54% | 45,770,042 | 63.62B |
| 14 | DHR | Danaher Corporation | 165.41B | 2.12% | 3,630,575 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 159.65B | 1.71% | 2,155,391 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 139.67B | 0.69% | 1,214,013 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.02B | - | 7,668,215 | 50.03B |
| 18 | MDT | Medtronic plc | 125.83B | 0.97% | 5,741,547 | 37.54B |
| 19 | SYK | Stryker Corporation | 124.00B | -0.04% | 2,551,465 | 26.30B |
| 20 | MCK | McKesson Corporation | 122.31B | -0.14% | 490,689 | 418.79B |
| 21 | SNY | Sanofi | 115.11B | 2.30% | 5,772,227 | 57.89B |
| 22 | CVS | CVS Health Corporation | 109.08B | 1.67% | 11,253,761 | 418.16B |
| 23 | MRNA | Moderna, Inc. | 108.84B | 5.83% | 12,357,426 | 2.53B |
| 24 | HCA | HCA Healthcare, Inc. | 105.47B | 2.00% | 954,398 | 78.70B |
| 25 | GSK | GSK plc | 102.42B | 2.40% | 3,572,614 | 44.53B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 92.32B | 1.73% | 856,756 | 16.90B |
| 27 | ELV | Elevance Health, Inc. | 90.37B | -1.73% | 1,401,293 | 201.83B |
| 28 | CI | The Cigna Group | 77.89B | 0.68% | 1,876,279 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 66.64B | 0.33% | 2,162,572 | 29.86B |
| 30 | COR | Cencora, Inc. | 65.98B | 3.66% | 1,942,674 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 63.81B | 2.97% | 16,195,827 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 63.40B | 0.95% | 1,383,420 | 257.75B |
| 33 | EW | Edwards Lifesciences Corporation | 60.21B | 2.52% | 6,683,075 | 6.67B |
| 34 | ARGX | argenx SE | 59.82B | 3.78% | 442,904 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 58.63B | 1.59% | 2,039,095 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 55.67B | 4.53% | 703,733 | 4.66B |
| 37 | MDLN | Medline Inc. | 53.55B | 2.70% | 7,464,614 | 30.68B |
| 38 | HUM | Humana Inc. | 50.83B | -2.43% | 2,451,037 | 154.19B |
| 39 | A | Agilent Technologies, Inc. | 50.80B | 3.10% | 2,171,249 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 50.14B | 0.84% | 4,578,130 | 17.23B |
| 41 | VEEV | Veeva Systems Inc. | 49.61B | 0.88% | 1,233,499 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 47.67B | 2.55% | 567,610 | 6.45B |
| 43 | WAT | Waters Corporation | 46.83B | 4.17% | 1,137,442 | 5.61B |
| 44 | NTRA | Natera, Inc. | 46.46B | 3.13% | 2,784,479 | 2.91B |
| 45 | IQV | IQVIA Holdings Inc. | 45.95B | 2.58% | 1,466,770 | 17.31B |
| 46 | RVMD | Revolution Medicines, Inc. | 43.29B | 4.09% | 2,560,705 | 197.56M |
| 47 | RPRX | Royalty Pharma plc | 39.45B | 2.18% | 3,738,137 | 2.62B |
| 48 | HLN | Haleon plc | 39.02B | -1.86% | 14,544,526 | 14.80B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.99B | 2.00% | 4,240,965 | 21.64B |
| 50 | BIIB | Biogen Inc. | 37.67B | 2.63% | 1,143,245 | 10.30B |
| 51 | ALC | Alcon Inc. | 36.03B | 0.27% | 2,815,981 | 10.86B |
| 52 | MTD | Mettler-Toledo International Inc. | 35.05B | 2.33% | 179,928 | 4.20B |
| 53 | GMAB | Genmab A/S | 34.73B | 4.05% | 5,137,139 | 4.30B |
| 54 | CNC | Centene Corporation | 33.93B | -1.72% | 5,706,202 | 180.41B |
| 55 | ZTS | Zoetis Inc. | 33.45B | 3.68% | 6,205,133 | 9.49B |
| 56 | ILMN | Illumina, Inc. | 33.38B | 3.59% | 1,863,768 | 4.54B |
| 57 | RMD | ResMed Inc. | 33.16B | 0.19% | 1,206,635 | 5.73B |
| 58 | DXCM | DexCom, Inc. | 30.24B | 2.09% | 4,099,334 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 30.19B | 1.43% | 797,777 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 29.90B | 1.45% | 1,448,392 | 20.16B |
| 61 | ROIV | Roivant Sciences Ltd. | 29.47B | 4.60% | 12,243,353 | 41.08M |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.78B | 3.32% | 555,262 | 3.40B |
| 63 | DGX | Quest Diagnostics Incorporated | 28.57B | 1.58% | 1,041,835 | 11.84B |
| 64 | INSM | Insmed Incorporated | 25.47B | 1.48% | 2,668,855 | 1.52B |
| 65 | STE | STERIS plc | 24.95B | 1.84% | 1,131,659 | 6.17B |
| 66 | INCY | Incyte Corporation | 24.85B | 1.87% | 1,154,647 | 6.01B |
| 67 | UTHR | United Therapeutics Corporation | 24.81B | 3.64% | 571,822 | 3.19B |
| 68 | VTRS | Viatris Inc. | 23.49B | 2.91% | 12,636,610 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 23.00B | 2.00% | 1,094,230 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.70B | - | 1,142,937 | 2.75B |
| 71 | GH | Guardant Health, Inc. | 21.48B | 5.25% | 3,142,509 | 1.28B |
| 72 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.98B | 0.43% | 3,303,358 | 5.01B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 20.50B | 2.59% | 2,512,522 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.82B | 3.03% | 219,169 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.93B | 3.62% | 1,723,073 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.51B | 3.12% | 4,826,248 | 2.50B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 17.09B | 2.57% | 1,525,253 | 3.70B |
| 78 | ASND | Ascendis Pharma A/S | 17.07B | 1.18% | 895,979 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.93B | 4.69% | 943,312 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.63B | 3.74% | 886,049 | 4.72B |
| 81 | ICLR | ICON Public Limited Company | 15.55B | 1.39% | 1,043,676 | 8.23B |
| 82 | TEM | Tempus AI, Inc. | 15.40B | 11.03% | 8,125,587 | 1.51B |
| 83 | SOLV | Solventum Corporation | 15.35B | 0.06% | 1,291,797 | 8.16B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 15.18B | 4.90% | 3,000,308 | 945.54M |
| 85 | BTSG | BrightSpring Health Services, Inc. | 14.41B | 2.98% | 2,171,181 | 15.25B |
| 86 | SMMT | Summit Therapeutics Inc. | 14.27B | 9.25% | 7,249,531 | - |
| 87 | GKOS | Glaukos Corporation | 14.13B | 6.39% | 854,096 | 690.33M |
| 88 | EHC | Encompass Health Corporation | 13.85B | 2.62% | 1,275,467 | 6.34B |
| 89 | BAX | Baxter International Inc. | 13.66B | 2.40% | 4,538,673 | 11.61B |
| 90 | ELAN | Elanco Animal Health Incorporated | 13.42B | 4.27% | 7,974,805 | 5.15B |
| 91 | SNN | Smith & Nephew plc | 12.81B | -0.32% | 1,335,403 | 6.30B |
| 92 | PEN | Penumbra, Inc. | 12.69B | 0.83% | 251,285 | 1.56B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 12.31B | 0.94% | 2,591,641 | 3.44B |
| 94 | ALGN | Align Technology, Inc. | 12.28B | 4.98% | 2,393,661 | 4.16B |
| 95 | COO | The Cooper Companies, Inc. | 12.16B | 2.52% | 2,348,516 | 4.24B |
| 96 | FMS | Fresenius Medical Care AG | 11.91B | -1.92% | 970,036 | 22.12B |
| 97 | KYMR | Kymera Therapeutics, Inc. | 11.85B | 5.41% | 1,268,041 | 102.24M |
| 98 | HALO | Halozyme Therapeutics, Inc. | 11.73B | -0.69% | 2,926,864 | 1.80B |
| 99 | DVA | DaVita Inc. | 11.67B | -3.04% | 749,869 | 14.17B |
| 100 | TECH | Bio-Techne Corporation | 11.44B | 0.07% | 2,668,052 | 1.23B |
| 101 | RGEN | Repligen Corporation | 11.44B | 3.14% | 1,096,250 | 805.61M |
| 102 | UHS | Universal Health Services, Inc. | 11.37B | 0.85% | 687,769 | 18.35B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 11.08B | 2.05% | 2,066,857 | 3.66B |
| 104 | AVTR | Avantor, Inc. | 10.78B | 2.84% | 8,125,416 | 6.64B |
| 105 | PCVX | Vaxcyte, Inc. | 10.69B | 5.70% | 1,252,299 | - |
| 106 | MOH | Molina Healthcare, Inc. | 10.59B | -2.70% | 807,819 | 42.08B |
| 107 | ENSG | The Ensign Group, Inc. | 10.53B | 0.56% | 317,532 | 5.67B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.44B | 1.77% | 547,369 | 2.59B |
| 109 | QGEN | Qiagen N.V. | 10.44B | 0.44% | 5,388,368 | 2.12B |
| 110 | PODD | Insulet Corporation | 10.39B | 2.25% | 1,332,171 | 3.19B |
| 111 | SYRE | Spyre Therapeutics, Inc. | 10.35B | 4.95% | 1,393,651 | - |
| 112 | BRKR | Bruker Corporation | 10.16B | 8.53% | 2,858,355 | 3.51B |
| 113 | GMED | Globus Medical, Inc. | 10.12B | 7.49% | 3,660,010 | 3.14B |
| 114 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.05B | 8.30% | 571,377 | 1.43B |
| 115 | OSCR | Oscar Health, Inc. | 9.98B | 4.86% | 7,639,341 | 17.47B |
| 116 | HNGE | Hinge Health, Inc. | 9.86B | 5.55% | 2,014,788 | 800.82M |
| 117 | HSIC | Henry Schein, Inc. | 9.77B | 2.74% | 1,761,927 | 13.73B |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 9.30B | 19.94% | 1,120,732 | 7.46M |
| 119 | ATR | AptarGroup, Inc. | 9.14B | 1.14% | 564,397 | 3.99B |
| 120 | TGTX | TG Therapeutics, Inc. | 8.99B | 5.93% | 4,929,256 | 897.76M |
| 121 | KRYS | Krystal Biotech, Inc. | 8.98B | 0.72% | 281,830 | 470.03M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.87B | 2.92% | 607,112 | 551.69M |
| 123 | TXG | 10x Genomics, Inc. | 8.56B | 9.73% | 2,773,070 | 618.58M |
| 124 | TWST | Twist Bioscience Corporation | 8.49B | 12.05% | 1,669,950 | 431.80M |
| 125 | HQY | HealthEquity, Inc. | 8.45B | -1.47% | 849,477 | 1.36B |
| 126 | CORT | Corcept Therapeutics Incorporated | 8.21B | 3.10% | 1,653,862 | 963.65M |
| 127 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.90B | 1.48% | 1,287,205 | 280.75M |
| 128 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.76B | 5.22% | 792,817 | 945.96M |
| 129 | ALKS | Alkermes plc | 7.76B | 0.59% | 1,709,147 | 1.75B |
| 130 | PACS | PACS Group, Inc. | 7.74B | -1.67% | 988,326 | 5.71B |
| 131 | CYTK | Cytokinetics, Incorporated | 7.68B | 2.70% | 3,119,553 | 113.29M |
| 132 | GRFS | Grifols, S.A. | 7.61B | 3.08% | 1,186,163 | 8.63B |
| 133 | ABVX | ABIVAX Société Anonyme | 7.59B | 1.48% | 564,795 | 5.33M |
| 134 | IBRX | ImmunityBio, Inc. | 7.56B | -17.71% | 44,873,120 | 182.57M |
| 135 | BLCO | Bausch + Lomb Corporation | 7.49B | 4.85% | 742,330 | 5.42B |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.41B | 5.66% | 2,627,700 | 3.20B |
| 137 | CAI | Caris Life Sciences, Inc. | 7.33B | 1.35% | 4,902,264 | 1.05B |
| 138 | IMVT | Immunovant, Inc. | 7.27B | 15.13% | 3,979,194 | - |
| 139 | AXSM | Axsome Therapeutics, Inc. | 7.05B | 1.20% | 1,117,954 | 865.27M |
| 140 | CHE | Chemed Corporation | 6.97B | 1.90% | 162,031 | 2.66B |
| 141 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.96B | -15.34% | 8,055,056 | 669.50M |
| 142 | ORKA | Oruka Therapeutics, Inc. | 6.92B | 1.65% | 1,598,908 | - |
| 143 | KOD | Kodiak Sciences Inc. | 6.72B | 7.85% | 1,128,184 | - |
| 144 | CGON | CG Oncology, Inc. | 6.68B | -1.64% | 1,511,599 | 6.17M |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.61B | 0.40% | 680,586 | 1.56B |
| 146 | BLTE | Belite Bio, Inc | 6.35B | 2.27% | 254,596 | - |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.28B | 2.60% | 140,283 | 253.83M |
| 148 | SRRK | Scholar Rock Holding Corporation | 6.28B | 9.82% | 2,796,767 | - |
| 149 | RDNT | RadNet, Inc. | 6.17B | 3.13% | 1,260,819 | 2.38B |
| 150 | TFX | Teleflex Incorporated | 6.14B | 2.56% | 994,008 | 2.26B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 6.08B | -0.58% | 709,690 | 670.78M |
| 152 | MANE | Veradermics, Incorporated | 6.01B | 3.73% | 492,150 | - |
| 153 | DOCS | Doximity, Inc. | 5.86B | 1.11% | 3,072,649 | 661.58M |
| 154 | COGT | Cogent Biosciences, Inc. | 5.84B | 5.97% | 1,689,878 | - |
| 155 | GRAL | GRAIL, Inc. | 5.76B | 5.47% | 809,470 | 166.60M |
| 156 | SUPN | Supernus, Inc. | 5.74B | 5.58% | 4,203,149 | 1.37B |
| 157 | WAY | Waystar Holding Corp. | 5.61B | 2.93% | 990,709 | 1.26B |
| 158 | LFST | LifeStance Health Group, Inc. | 5.55B | 6.03% | 29,534,956 | 1.68B |
| 159 | BLLN | BillionToOne, Inc. | 5.49B | 0.89% | 691,206 | 436.87M |
| 160 | ERAS | Erasca, Inc. | 5.46B | 8.33% | 4,702,089 | - |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.43B | -0.63% | 843,279 | 1.16B |
| 162 | HAE | Haemonetics Corporation | 5.38B | -1.43% | 999,316 | 1.38B |
| 163 | CON | Concentra Group Holdings Parent, Inc. | 5.36B | 0.43% | 1,066,499 | 2.34B |
| 164 | HIMS | Hims & Hers Health, Inc. | 5.35B | -11.77% | 50,147,238 | 2.87B |
| 165 | EWTX | Edgewise Therapeutics, Inc. | 5.34B | 8.21% | 2,588,695 | - |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.30B | 1.36% | 507,103 | 1.61B |
| 167 | IONS | Ionis Pharmaceuticals, Inc. | 5.16B | -21.36% | 19,508,605 | 960.09M |
| 168 | LIVN | LivaNova PLC | 5.10B | 2.91% | 628,661 | 1.51B |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 5.07B | 4.61% | 704,035 | 2.72M |
| 170 | MMED | MiniMed Group, Inc. | 5.03B | 7.00% | 6,196,579 | 3.22B |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.96B | 4.09% | 2,067,886 | 651.03M |
| 172 | HTFL | HeartFlow, Inc. | 4.93B | 8.13% | 1,652,968 | 212.07M |
| 173 | ADPT | Adaptive Biotechnologies Corporation | 4.90B | 8.15% | 2,831,590 | 298.01M |
| 174 | CRSP | CRISPR Therapeutics AG | 4.85B | -0.06% | 1,060,389 | 25.17M |
| 175 | DFTX | Definium Therapeutics, Inc. | 4.76B | 6.37% | 1,414,388 | - |
| 176 | OPCH | Option Care Health, Inc. | 4.75B | 0.13% | 3,450,404 | 5.75B |
| 177 | LEGN | Legend Biotech Corporation | 4.71B | 3.80% | 2,040,881 | 1.27B |
| 178 | SHC | Sotera Health Company | 4.70B | 2.69% | 2,872,635 | 1.23B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.51B | 9.62% | 3,848,132 | 10.35M |
| 180 | ICUI | ICU Medical, Inc. | 4.47B | 3.92% | 344,711 | 2.18B |
| 181 | CDNA | CareDx, Inc. | 4.44B | 7.46% | 1,094,625 | 497.40M |
| 182 | ITGR | Integer Holdings Corporation | 4.30B | - | 714,858 | 1.83B |
| 183 | LQDA | Liquidia Corporation | 4.28B | 7.82% | 2,160,868 | 450.91M |
| 184 | PLSE | Pulse Biosciences, Inc. | 4.28B | 9.16% | 534,705 | 1.49M |
| 185 | NVST | Envista Holdings Corporation | 4.16B | 3.18% | 3,424,522 | 2.88B |
| 186 | ABCL | AbCellera Biologics Inc. | 4.05B | 5.22% | 2,999,372 | 66.17M |
| 187 | XENE | Xenon Pharmaceuticals Inc. | 3.92B | 3.27% | 1,606,861 | 7.50M |
| 188 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.88B | 2.41% | 1,297,566 | -665.00K |
| 189 | TNGX | Tango Therapeutics, Inc. | 3.85B | 5.77% | 2,516,744 | 53.81M |
| 190 | ELVN | Enliven Therapeutics, Inc. | 3.79B | 4.29% | 697,165 | - |
| 191 | IOVA | Iovance Biotherapeutics, Inc. | 3.78B | 1.62% | 13,689,669 | 378.98M |
| 192 | WRBY | Warby Parker Inc. | 3.76B | 18.56% | 11,380,139 | 934.66M |
| 193 | PBLS | Parabilis Medicines, Inc. | 3.75B | 6.45% | 950,738 | 148.00K |
| 194 | STVN | Stevanato Group S.p.A. | 3.75B | 1.18% | 1,004,938 | 1.42B |
| 195 | IRON | Disc Medicine, Inc. | 3.70B | 2.98% | 912,032 | - |
| 196 | VKTX | Viking Therapeutics, Inc. | 3.70B | 8.01% | 4,099,802 | - |
| 197 | OGN | Organon & Co. | 3.64B | - | 2,985,108 | 6.10B |
| 198 | ACHC | Acadia Healthcare Company, Inc. | 3.59B | 4.35% | 2,660,761 | 3.41B |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.49B | 3.27% | 1,052,066 | 682.20M |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.49B | 3.04% | 3,860,445 | - |
| 201 | CELC | Celcuity Inc. | 3.46B | 5.36% | 922,008 | - |
| 202 | SGRY | Surgery Partners, Inc. | 3.43B | 14.01% | 17,054,657 | 3.36B |
| 203 | VRDN | Viridian Therapeutics, Inc. | 3.43B | 5.97% | 3,907,311 | 26.31M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.31B | 2.54% | 2,763,835 | 508.68M |
| 205 | NHC | National HealthCare Corporation | 3.29B | 0.43% | 158,375 | 1.58B |
| 206 | TLX | Telix Pharmaceuticals Limited | 3.27B | 2.70% | 405,356 | 890.79M |
| 207 | DNLI | Denali Therapeutics Inc. | 3.26B | 1.30% | 1,384,164 | 21.38M |
| 208 | TMDX | TransMedics Group, Inc. | 3.26B | 6.29% | 2,066,178 | 727.65M |
| 209 | BHC | Bausch Health Companies Inc. | 3.14B | 2.69% | 3,952,086 | 11.11B |
| 210 | PRVA | Privia Health Group, Inc. | 3.14B | 0.49% | 1,725,801 | 2.43B |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 3.10B | 2.53% | 884,957 | 36.54M |
| 212 | AXGN | Axogen, Inc. | 3.02B | 1.24% | 1,360,968 | 266.93M |
| 213 | ZLAB | Zai Lab Limited | 3.02B | 5.42% | 2,102,593 | 441.73M |
| 214 | IRTC | iRhythm Holdings, Inc. | 2.98B | -1.65% | 1,439,211 | 854.04M |
| 215 | VCEL | Vericel Corporation | 2.98B | 6.90% | 1,750,784 | 324.17M |
| 216 | GRDN | Guardian Pharmacy Services, Inc. | 2.98B | 10.92% | 932,561 | 1.46B |
| 217 | ATRC | AtriCure, Inc. | 2.94B | -1.30% | 1,096,486 | 589.80M |
| 218 | XERS | Xeris Biopharma Holdings, Inc. | 2.90B | 4.34% | 5,937,182 | 368.26M |
| 219 | XNCR | Xencor, Inc. | 2.90B | 7.94% | 1,958,284 | 200.49M |
| 220 | AVAH | Aveanna Healthcare Holdings Inc. | 2.88B | -0.38% | 1,898,040 | 2.60B |
| 221 | ACAD | Acadia Pharmaceuticals Inc. | 2.85B | -22.28% | 12,150,929 | 1.20B |
| 222 | ADMA | ADMA Biologics, Inc. | 2.84B | 0.47% | 3,366,980 | 519.15M |
| 223 | RGC | Regencell Bioscience Holdings Limited | 2.79B | 6.74% | 191,588 | - |
| 224 | RCUS | Arcus Biosciences, Inc. | 2.73B | 3.67% | 976,100 | 100.00M |
| 225 | BEAM | Beam Therapeutics Inc. | 2.69B | 2.31% | 1,292,255 | 146.64M |
| 226 | HCM | HUTCHMED (China) Limited | 2.66B | 1.06% | 59,211 | 549.12M |
| 227 | PGNY | Progyny, Inc. | 2.65B | 3.19% | 1,645,335 | 1.34B |
| 228 | NEOG | Neogen Corporation | 2.64B | 2.72% | 8,406,056 | 884.00M |
| 229 | MBX | MBX Biosciences, Inc. | 2.60B | 5.28% | 666,076 | - |
| 230 | CLOV | Clover Health Investments, Corp. | 2.59B | 0.21% | 8,436,439 | 2.74B |
| 231 | PVLA | Palvella Therapeutics, Inc. | 2.54B | -1.05% | 364,538 | - |
| 232 | ARDT | Ardent Health, Inc. | 2.53B | 3.87% | 1,589,116 | 6.45B |
| 233 | SDGR | Schrödinger, Inc. | 2.51B | 11.97% | 2,710,563 | 269.20M |
| 234 | UFPT | UFP Technologies, Inc. | 2.47B | 5.07% | 88,913 | 649.52M |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.45B | 4.59% | 1,858,121 | 158.00K |
| 236 | PHVS | Pharvaris N.V. | 2.42B | 0.23% | 638,334 | - |
| 237 | MD | Pediatrix Medical Group, Inc. | 2.40B | 0.64% | 416,650 | 1.96B |
| 238 | RXRX | Recursion Pharmaceuticals, Inc. | 2.37B | 8.10% | 20,366,667 | 68.23M |
| 239 | SEPN | Septerna, Inc. | 2.37B | 3.87% | 713,679 | 96.27M |
| 240 | PRGO | Perrigo Company plc | 2.35B | 6.94% | 2,917,221 | 4.09B |
| 241 | VIR | Vir Biotechnology, Inc. | 2.34B | 11.75% | 7,123,802 | 302.80M |
| 242 | BHVN | Biohaven Ltd. | 2.30B | 5.18% | 3,632,509 | - |
| 243 | IMNM | Immunome, Inc. | 2.28B | 3.47% | 1,376,712 | 4.02M |
| 244 | NAMS | NewAmsterdam Pharma Company N.V. | 2.28B | 0.53% | 2,762,196 | 25.94M |
| 245 | NEO | NeoGenomics, Inc. | 2.28B | 4.51% | 1,162,902 | 787.75M |
| 246 | ADUS | Addus HomeCare Corporation | 2.23B | -1.52% | 345,143 | 1.50B |
| 247 | BKD | Brookdale Senior Living Inc. | 2.23B | 3.33% | 10,837,075 | 2.86B |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 0.97% | 682,268 | 321.74M |
| 249 | VERA | Vera Therapeutics, Inc. | 2.21B | 2.75% | 1,392,182 | 10.28M |
| 250 | ALMR | Alamar Biosciences, Inc. | 2.21B | 13.51% | 672,795 | 114.05M |
| 251 | ZYME | Zymeworks Inc. | 2.19B | 3.98% | 1,164,338 | 265.97M |
| 252 | TRVI | Trevi Therapeutics, Inc. | 2.18B | 6.84% | 1,444,180 | - |
| 253 | FTRE | Fortrea Holdings Inc. | 2.15B | 1.28% | 1,361,864 | 2.67B |
| 254 | LKFT | Lakefront Biotherapeutics NV | 2.14B | 0.21% | 325,971 | 1.13B |
| 255 | TRLV | Trulieve Cannabis Corp. | 2.12B | -4.76% | 1,898,961 | 1.08B |
| 256 | REPL | Replimune Group, Inc. | 2.11B | 2.96% | 3,204,563 | - |
| 257 | VCYT | Veracyte, Inc. | 2.09B | 7.28% | 5,064,631 | 581.78M |
| 258 | TRAX | First Tracks Biotherapeutics, Inc. | 2.09B | 3.76% | 808,491 | - |
| 259 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.08B | 6.65% | 2,146,690 | 213.00M |
| 260 | PBH | Prestige Consumer Healthcare Inc. | 2.07B | 1.61% | 619,208 | 1.17B |
| 261 | ESTA | Establishment Labs Holdings Inc. | 2.04B | 2.24% | 331,164 | 264.03M |
| 262 | COAG | Hemab Therapeutics Holdings, Inc. | 2.00B | -12.67% | 1,095,989 | - |
| 263 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | 2.02% | 792,930 | 989.36M |
| 264 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.96B | -0.78% | 5,516,820 | 961.51M |
| 265 | WGS | GeneDx Holdings Corp. | 1.96B | 5.37% | 1,868,797 | 460.78M |
| 266 | ZBIO | Zenas BioPharma, Inc. | 1.94B | 1.10% | 634,859 | 11.00M |
| 267 | AGL | agilon health, inc. | 1.92B | 0.56% | 171,634 | 6.00B |
| 268 | XRAY | DENTSPLY SIRONA Inc. | 1.89B | 0.85% | 5,743,303 | 3.58B |
| 269 | MAZE | Maze Therapeutics, Inc. | 1.88B | 2.11% | 510,325 | 20.00M |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.88B | 6.70% | 1,341,937 | 140.84M |
| 271 | MESO | Mesoblast Limited | 1.87B | 1.19% | 83,355 | 120.25M |
| 272 | CERT | Certara, Inc. | 1.86B | 1.41% | 5,842,302 | 425.76M |
| 273 | INSP | Inspire Medical Systems, Inc. | 1.86B | 0.55% | 521,590 | 880.94M |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.86B | 0.33% | 185,931 | 269.36M |
| 275 | ETON | Eton Pharmaceuticals, Inc. | 1.86B | 13.97% | 1,139,254 | 141.06M |
| 276 | ABSI | Absci Corporation | 1.85B | 6.19% | 3,756,830 | 1.56M |
| 277 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -3.25% | 2,480,505 | 1.96B |
| 278 | GENB | Generate Biomedicines, Inc. | 1.82B | 8.58% | 669,528 | 26.48M |
| 279 | STOK | Stoke Therapeutics, Inc. | 1.81B | 4.41% | 1,059,985 | 28.21M |
| 280 | NVAX | Novavax, Inc. | 1.80B | 1.02% | 8,495,573 | 411.65M |
| 281 | KMTS | Kestra Medical Technologies, Ltd. | 1.79B | 4.58% | 441,958 | 106.73M |
| 282 | AZTA | Azenta, Inc. | 1.79B | 4.57% | 733,901 | 613.81M |
| 283 | BFLY | Butterfly Network, Inc. | 1.78B | 4.71% | 3,813,258 | 123.26M |
| 284 | KLRA | Kailera Therapeutics, Inc. | 1.78B | 5.63% | 1,393,731 | - |
| 285 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 5.49% | 7,595,137 | 701.94M |
| 286 | LYCA | Lycia Therapeutics, Inc. | 1.75B | -0.46% | 184,458 | 4.44M |
| 287 | SLS | SELLAS Life Sciences Group, Inc. | 1.73B | 1.90% | 4,786,731 | - |
| 288 | ASTH | Astrana Health, Inc. | 1.73B | -2.12% | 710,203 | 3.91B |
| 289 | PSNL | Personalis, Inc. | 1.73B | 1.01% | 2,324,444 | 80.77M |
| 290 | OMCL | Omnicell, Inc. | 1.72B | 0.03% | 495,903 | 1.24B |
| 291 | NTLA | Intellia Therapeutics, Inc. | 1.70B | 6.70% | 4,173,361 | 52.89M |
| 292 | PGEN | Precigen, Inc. | 1.70B | 5.82% | 8,815,750 | 156.94M |
| 293 | ALVO | Alvotech | 1.67B | -3.50% | 1,265,759 | 494.61M |
| 294 | HCSG | Healthcare Services Group, Inc. | 1.67B | 2.06% | 457,848 | 1.88B |
| 295 | RARE | Ultragenyx Pharmaceutical Inc. | 1.67B | 6.35% | 2,669,212 | 730.00M |
| 296 | ENOV | Enovis Corporation | 1.65B | 5.08% | 1,614,483 | 2.31B |
| 297 | IMCR | Immunocore Holdings plc | 1.64B | 2.39% | 554,355 | 429.30M |
| 298 | TDOC | Teladoc Health, Inc. | 1.64B | 2.39% | 4,038,106 | 2.47B |
| 299 | NBTX | Nanobiotix S.A. | 1.62B | 4.57% | 171,486 | 13.15M |
| 300 | SNDA | Sonida Senior Living, Inc. | 1.61B | 1.34% | 659,597 | 593.56M |
| 301 | QURE | uniQure N.V. | 1.60B | 5.02% | 1,322,474 | 20.17M |
| 302 | BRVE | Braveheart Bio, Inc. | 1.59B | 4.62% | 618,351 | - |
| 303 | CNMD | CONMED Corporation | 1.55B | 0.85% | 375,677 | 1.37B |
| 304 | ADRX | ADARx Pharmaceuticals, Inc. | 1.55B | 4.31% | 357,034 | 6.13M |
| 305 | RAPP | Rapport Therapeutics, Inc. | 1.55B | 6.67% | 789,397 | 20.00M |
| 306 | NUVB | Nuvation Bio Inc. | 1.54B | 4.57% | 5,326,870 | 201.73M |
| 307 | TYRA | Tyra Biosciences, Inc. | 1.53B | 5.44% | 343,154 | - |
| 308 | GPCR | Structure Therapeutics Inc. | 1.53B | 5.21% | 1,235,658 | - |
| 309 | ALHC | Alignment Healthcare, Inc. | 1.52B | -0.95% | 3,437,882 | 4.94B |
| 310 | OCUL | Ocular Therapeutix, Inc. | 1.51B | 3.79% | 3,556,073 | 50.38M |
| 311 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 0.35% | 324,943 | 829.86M |
| 312 | DMRA | Damora Therapeutics, Inc. | 1.49B | 1.56% | 564,143 | - |
| 313 | NVCR | NovoCure Limited | 1.46B | -5.65% | 2,797,535 | 725.39M |
| 314 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.08% | 523,016 | 743.30M |
| 315 | LBRX | LB Pharmaceuticals Inc | 1.46B | 7.40% | 472,435 | - |
| 316 | AMN | AMN Healthcare Services, Inc. | 1.45B | 4.20% | 1,566,736 | 3.52B |
| 317 | ANIP | ANI Pharmaceuticals, Inc. | 1.44B | 0.56% | 483,964 | 1.04B |
| 318 | ANAB | AnaptysBio, Inc. | 1.43B | 3.27% | 323,841 | 106.09M |
| 319 | TSHA | Taysha Gene Therapies, Inc. | 1.42B | 0.92% | 3,357,217 | 5.49M |
| 320 | KRSA | Korsana Biosciences, Inc. | 1.42B | 0.39% | 159,942 | - |
| 321 | KARD | Kardigan, Inc. | 1.42B | -2.19% | 421,133 | - |
| 322 | PAHC | Phibro Animal Health Corporation | 1.41B | 5.01% | 282,682 | 1.54B |
| 323 | AAPG | Ascentage Pharma Group International | 1.40B | -0.45% | 5,286 | 94.61M |
| 324 | MLYS | Mineralys Therapeutics, Inc. | 1.40B | 3.13% | 2,960,863 | - |
| 325 | INVA | Innoviva, Inc. | 1.35B | -0.52% | 1,662,240 | 438.32M |
| 326 | INBX | Inhibrx Biosciences, Inc. | 1.35B | 8.54% | 185,738 | 1.30M |
| 327 | MNKD | MannKind Corporation | 1.35B | 7.44% | 4,833,266 | 413.37M |
| 328 | LMRI | Lumexa Imaging Holdings, Inc. | 1.34B | 4.02% | 365,485 | 1.04B |
| 329 | NUTX | Nutex Health Inc. | 1.33B | 7.53% | 153,909 | 796.53M |
| 330 | GHRS | GH Research PLC | 1.32B | 3.49% | 195,613 | - |
| 331 | CRON | Cronos Group Inc. | 1.31B | -1.94% | 1,481,585 | 206.20M |
| 332 | AVLN | Avalyn Pharma Inc. | 1.31B | 1.20% | 796,814 | - |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.30B | 2.84% | 500,268 | - |
| 334 | CMPS | COMPASS Pathways plc | 1.30B | 6.62% | 3,414,743 | - |
| 335 | NKTR | Nektar Therapeutics | 1.29B | 1.52% | 684,337 | 54.59M |
| 336 | URGN | UroGen Pharma Ltd. | 1.29B | 6.30% | 1,493,034 | 250.25M |
| 337 | PRCT | PROCEPT BioRobotics Corporation | 1.29B | 8.49% | 1,718,032 | 352.31M |
| 338 | SGP | SpyGlass Pharma, Inc. | 1.28B | 3.84% | 227,241 | - |
| 339 | SVRA | Savara Inc. | 1.28B | 4.55% | 2,404,138 | - |
| 340 | PNTG | The Pennant Group, Inc. | 1.27B | -0.28% | 741,799 | 1.17B |
| 341 | OMER | Omeros Corporation | 1.27B | 3.72% | 765,582 | 38.42M |
| 342 | OPK | OPKO Health, Inc. | 1.27B | -1.16% | 3,081,246 | 654.10M |
| 343 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | 7.45% | 2,639,243 | 1.08B |
| 344 | INNV | InnovAge Holding Corp. | 1.26B | 2.68% | 292,465 | 1.02B |
| 345 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.25B | 3.12% | 635,804 | 745.79M |
| 346 | GDRX | GoodRx Holdings, Inc. | 1.25B | 3.99% | 1,019,013 | 785.23M |
| 347 | STAA | STAAR Surgical Company | 1.23B | -2.62% | 1,669,964 | 328.27M |
| 348 | SLN | Silence Therapeutics plc | 1.23B | 0.10% | 1,377,350 | 615.00K |
| 349 | VOR | Vor Biopharma Inc. | 1.23B | 0.50% | 1,095,637 | - |
| 350 | SPTX | Seaport Therapeutics, Inc. | 1.17B | 1.98% | 306,864 | - |
| 351 | SIBN | SI-BONE, Inc. | 1.15B | 5.61% | 1,438,675 | 220.65M |
| 352 | ATEC | Alphatec Holdings, Inc. | 1.14B | -0.81% | 3,565,711 | 839.72M |
| 353 | FRNM | Freenome, Inc. | 1.14B | 3.83% | 1,054,993 | 35.41M |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.12B | 7.08% | 1,035,814 | 1.66B |
| 355 | IRMD | IRADIMED CORPORATION | 1.11B | 0.73% | 102,587 | 89.34M |
| 356 | AHG | Akso Health Group | 1.10B | -5.19% | 7,197 | 13.83M |
| 357 | VSTM | Verastem, Inc. | 1.10B | 3.45% | 2,756,069 | 100.30M |
| 358 | ANRO | Alto Neuroscience, Inc. | 1.09B | 10.49% | 824,853 | - |
| 359 | MLTX | MoonLake Immunotherapeutics | 1.07B | 9.45% | 1,592,627 | - |
| 360 | CBLL | CeriBell, Inc. | 1.07B | 3.80% | 338,240 | 108.72M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.06B | 5.72% | 563,385 | 377.13M |
| 362 | HROW | Harrow, Inc. | 1.03B | 2.16% | 1,170,744 | 303.25M |
| 363 | AORT | Artivion, Inc. | 1.01B | 2.13% | 1,662,774 | 481.88M |
| 364 | JBIO | Jade Biosciences, Inc. | 992.12M | 3.52% | 739,449 | - |
| 365 | AHCO | AdaptHealth Corp. | 981.89M | 0.27% | 1,865,062 | 3.44B |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 957.41M | 7.69% | 1,273,699 | - |
| 367 | ORIC | ORIC Pharmaceuticals, Inc. | 956.71M | 4.65% | 1,228,509 | - |
| 368 | OMDA | Omada Health, Inc. | 936.15M | - | 2,082,892 | 333.04M |
| 369 | CTY | City Therapeutics, Inc. | 928.96M | 2.30% | 245,419 | 14.34M |
| 370 | BVS | Bioventus Inc. | 928.13M | 3.82% | 746,654 | 585.64M |
| 371 | BBNX | Beta Bionics, Inc. | 921.52M | 7.96% | 656,519 | 127.27M |
| 372 | ODTX | Odyssey Therapeutics, Inc. | 918.07M | -0.42% | 621,344 | 99.00K |
| 373 | MGTX | MeiraGTx Holdings plc | 911.45M | 5.44% | 544,744 | 397.50M |
| 374 | PHAR | Pharming Group N.V. | 910.70M | 7.08% | 20,093 | 386.75M |
| 375 | AKTS | Aktis Oncology, Inc. | 910.49M | 3.48% | 468,057 | 10.06M |
| 376 | GLUE | Monte Rosa Therapeutics, Inc. | 904.06M | 0.09% | 1,367,242 | 70.33M |
| 377 | KIDS | OrthoPediatrics Corp. | 887.50M | 7.02% | 488,923 | 264.14M |
| 378 | LTGO | Latigo Biotherapeutics, Inc. | 885.10M | 5.95% | 326,434 | - |
| 379 | HSTM | HealthStream, Inc. | 883.76M | -0.14% | 267,151 | 327.95M |
| 380 | IVA | Inventiva S.A. | 881.48M | 1.05% | 1,572,882 | 2.81M |
| 381 | IMTX | Immatics N.V. | 878.92M | 1.10% | 691,621 | 47.65M |
| 382 | GMRS | GMR Solutions Inc. | 875.92M | -9.41% | 3,023,277 | 5.97B |
| 383 | BBTX | Bambusa Therapeutics, Inc. | 862.96M | 7.69% | 298,563 | - |
| 384 | SNDX | Syndax Pharmaceuticals, Inc. | 859.77M | 0.10% | 3,486,604 | 289.68M |
| 385 | ALMS | Alumis Inc. | 847.80M | 8.62% | 2,405,549 | 7.40M |
| 386 | OBX | Obsidian Therapeutics, Inc. | 846.91M | -1.15% | 1,143,735 | - |
| 387 | DNA | Ginkgo Bioworks Holdings, Inc. | 833.00M | 9.57% | 3,196,230 | 130.75M |
| 388 | QDEL | QuidelOrtho Corporation | 829.53M | 12.99% | 3,708,366 | 2.59B |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 810.33M | 2.25% | 2,561,399 | 38.54M |
| 390 | ANNX | Annexon, Inc. | 801.92M | 0.71% | 2,843,655 | - |
| 391 | PHR | Phreesia, Inc. | 800.72M | 2.22% | 455,156 | 507.79M |
| 392 | AURA | Aura Biosciences, Inc. | 797.21M | 16.77% | 1,128,664 | - |
| 393 | RIGL | Rigel Pharmaceuticals, Inc. | 791.80M | 6.05% | 310,277 | 288.21M |
| 394 | SLDB | Solid Biosciences Inc. | 783.51M | 6.53% | 2,373,416 | - |
| 395 | JANX | Janux Therapeutics, Inc. | 780.70M | -27.62% | 4,848,775 | 23.29M |
| 396 | VREX | Varex Imaging Corporation | 777.63M | 0.05% | 289,426 | 865.00M |
| 397 | INMD | InMode Ltd. | 776.57M | 1.35% | 525,784 | 374.63M |
| 398 | IRWD | Ironwood Pharmaceuticals, Inc. | 774.78M | 6.61% | 5,331,411 | 400.30M |
| 399 | OABI | OmniAb, Inc. | 773.06M | 5.37% | 2,474,143 | 40.21M |
| 400 | CTKB | Cytek Biosciences, Inc. | 770.32M | 1.03% | 1,488,409 | 207.65M |
| 401 | SGMT | Sagimet Biosciences Inc. | 767.94M | 9.95% | 1,093,943 | - |
| 402 | COLL | Collegium Pharmaceutical, Inc. | 767.87M | 2.07% | 628,849 | 815.19M |
| 403 | PRME | Prime Medicine, Inc. | 764.99M | -7.53% | 3,508,652 | 4.07M |
| 404 | CGEM | Cullinan Therapeutics, Inc. | 754.88M | 3.71% | 1,035,286 | - |
| 405 | SANA | Sana Biotechnology, Inc. | 738.60M | 4.01% | 3,264,979 | - |
| 406 | PACB | Pacific Biosciences of California, Inc. | 738.51M | 4.66% | 11,843,402 | 161.39M |
| 407 | ARDX | Ardelyx, Inc. | 736.52M | 1.74% | 6,448,180 | 468.22M |
| 408 | ABUS | Arbutus Biopharma Corporation | 735.99M | 1.78% | 1,709,343 | 181.72M |
| 409 | FLGT | Fulgent Genetics, Inc. | 730.60M | 10.15% | 973,978 | 330.28M |
| 410 | ATTO | Attovia Therapeutics, Inc. | 728.59M | 4.52% | 325,446 | 1.80M |
| 411 | CADL | Candel Therapeutics, Inc. | 726.16M | 8.46% | 1,371,305 | - |
| 412 | NVCT | Nuvectis Pharma, Inc. | 722.85M | 0.53% | 385,119 | - |
| 413 | ZVRA | Zevra Therapeutics, Inc. | 722.39M | 4.75% | 1,893,539 | 147.76M |
| 414 | ANL | Adlai Nortye Group Ltd. | 718.04M | 8.46% | 263,354 | 18.06M |
| 415 | IMMX | Immix Biopharma, Inc. | 710.48M | 6.33% | 1,270,841 | - |
| 416 | DCTH | Delcath Systems, Inc. | 705.15M | 35.77% | 3,449,206 | 109.96M |
| 417 | AVBP | ArriVent BioPharma, Inc. | 698.20M | 3.81% | 905,967 | 5.00M |
| 418 | ACHV | Achieve Life Sciences, Inc. | 697.68M | 0.89% | 1,089,178 | - |
| 419 | DSGN | Design Therapeutics, Inc. | 691.59M | 5.78% | 375,654 | - |
| 420 | DBVT | DBV Technologies S.A. | 689.94M | 5.74% | 416,639 | 3.74M |
| 421 | FDMT | 4D Molecular Therapeutics, Inc. | 689.45M | 1.88% | 879,815 | 92.01M |
| 422 | WVE | Wave Life Sciences, Inc. | 686.36M | 3.42% | 3,934,666 | 70.92M |
| 423 | HELP | Helus Pharma Inc. | 684.57M | 4.58% | 1,601,366 | - |
| 424 | KURA | Kura Oncology, Inc. | 673.43M | 4.13% | 2,102,648 | 77.23M |
| 425 | ACRS | Aclaris Therapeutics, Inc. | 672.52M | 8.72% | 2,027,708 | 6.40M |
| 426 | BCAX | Bicara Therapeutics Inc. | 660.41M | 15.38% | 1,834,558 | - |
| 427 | APMD | Apnimed, Inc. | 658.18M | 4.70% | 290,147 | 115.12M |
| 428 | CLYM | Climb Bio, Inc. | 646.71M | 7.00% | 1,783,991 | - |
| 429 | OLMA | Olema Pharmaceuticals, Inc. | 643.98M | 0.41% | 1,516,463 | - |
| 430 | GERN | Geron Corporation | 641.98M | 0.68% | 5,732,297 | 217.52M |
| 431 | SOPH | SOPHiA GENETICS SA | 641.58M | 4.90% | 556,830 | 90.97M |
| 432 | IAM | Iambic Therapeutics, Inc. | 634.22M | 31.56% | 899,208 | 18.25M |
| 433 | EVO | Evotec SE | 625.69M | 2.96% | 53,020 | 815.72M |
| 434 | SGHT | Sight Sciences, Inc. | 611.92M | 9.23% | 1,255,069 | 88.40M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 595.65M | 2.15% | 167,679 | 356.42M |
| 436 | CBIO | Crescent Biopharma, Inc. | 584.23M | 0.81% | 206,112 | 11.88M |
| 437 | AVR | Anteris Technologies Global Corp. | 579.11M | 4.39% | 669,391 | 2.24M |
| 438 | CAPR | Capricor Therapeutics, Inc. | 572.67M | 9.44% | 4,765,079 | 11.13M |
| 439 | NRC | NRC Health | 565.98M | 3.13% | 69,133 | 143.79M |
| 440 | ENTX | Entera Bio Ltd. | 565.25M | 3.50% | 512,163 | 42.00K |
| 441 | SRZN | Surrozen, Inc. | 559.85M | 3.23% | 120,851 | 10.53M |
| 442 | SLBT | SL Science Holding Limited | 557.95M | 4.36% | 10,590 | 3.27M |
| 443 | OVID | Ovid Therapeutics Inc. | 556.60M | - | 6,224,780 | 1.58M |
| 444 | VALN | Valneva SE | 551.62M | 2.72% | 9,913 | 163.30M |
| 445 | MYGN | Myriad Genetics, Inc. | 550.59M | -3.04% | 2,059,688 | 803.60M |
| 446 | SRTA | Strata Critical Medical, Inc. | 540.39M | 8.81% | 1,885,476 | 280.76M |
| 447 | TKNO | Alpha Teknova, Inc. | 537.82M | 9.48% | 428,240 | 45.95M |
| 448 | RGNX | REGENXBIO Inc. | 533.61M | 5.91% | 2,174,115 | 153.91M |
| 449 | EVH | Evolent Health, Inc. | 532.73M | 2.84% | 2,146,034 | 2.34B |
| 450 | RCEL | AVITA Medical, Inc. | 529.47M | 3.19% | 921,214 | 84.68M |
| 451 | DMAC | DiaMedica Therapeutics Inc. | 520.38M | 3.10% | 146,710 | - |
| 452 | NGNE | Neurogene Inc. | 520.30M | 2.73% | 442,083 | 925.00K |
| 453 | SENS | Senseonics Holdings, Inc. | 518.17M | 14.09% | 986,101 | 60.01M |
| 454 | ETRA | Electra Therapeutics, Inc. | 515.94M | 5.38% | 428,274 | - |
| 455 | ANGO | AngioDynamics, Inc. | 509.70M | 3.32% | 609,506 | 325.38M |
| 456 | GYRE | Gyre Therapeutics, Inc. | 508.95M | -2.31% | 224,596 | 110.06M |
| 457 | STTK | Shattuck Labs, Inc. | 508.19M | 8.01% | 1,271,399 | 1.00M |
| 458 | MNPR | Monopar Therapeutics Inc. | 495.02M | 3.26% | 124,853 | - |
| 459 | EPRX | Eupraxia Pharmaceuticals Inc. | 487.98M | 7.69% | 567,779 | - |
| 460 | MDXG | MiMedx Group, Inc. | 484.47M | 0.30% | 868,752 | 303.73M |
| 461 | INDP | Indaptus Therapeutics, Inc. | 480.71M | -5.72% | 189,798 | - |
| 462 | OCS | Oculis Holding AG | 479.04M | 3.60% | 339,858 | 1.12M |
| 463 | MASS | 908 Devices Inc. | 475.75M | 9.00% | 341,433 | 60.84M |
| 464 | YDES | YD Bio Limited | 475.28M | 12.40% | 40,155 | 1.24M |
| 465 | BWAY | BrainsWay Ltd. | 465.24M | 4.39% | 161,773 | 60.70M |
| 466 | EOLS | Evolus, Inc. | 461.99M | 2.50% | 1,150,209 | 325.47M |
| 467 | BLSM | BlossomHill Therapeutics, Inc. | 459.61M | 7.11% | 213,183 | - |
| 468 | PRTA | Prothena Corporation plc | 450.59M | 10.10% | 741,119 | 52.74M |
| 469 | NPCE | NeuroPace, Inc. | 450.33M | 4.96% | 235,695 | 106.99M |
| 470 | SI | Shoulder Innovations, Inc. | 449.00M | 4.48% | 245,844 | 64.49M |
| 471 | AQST | Aquestive Therapeutics, Inc. | 444.93M | -1.94% | 4,273,850 | 48.84M |
| 472 | ASMB | Assembly Biosciences, Inc. | 443.66M | 6.71% | 313,335 | 74.85M |
| 473 | ARVN | Arvinas, Inc. | 442.68M | 5.46% | 1,040,074 | 275.30M |
| 474 | RLMD | Relmada Therapeutics, Inc. | 441.61M | 6.15% | 958,592 | - |
| 475 | CARL | Carlsmed, Inc. | 438.21M | 10.54% | 162,629 | 63.30M |
| 476 | OBIO | Orchestra BioMed Holdings, Inc. | 435.78M | 0.35% | 785,151 | 31.98M |
| 477 | PBYI | Puma Biotechnology, Inc. | 433.35M | 1.76% | 750,644 | 231.87M |
| 478 | CTMX | CytomX Therapeutics, Inc. | 431.65M | -9.59% | 12,912,639 | 14.03M |
| 479 | KMDA | Kamada Ltd. | 428.36M | 6.64% | 171,845 | 196.87M |
| 480 | TECX | Tectonic Therapeutic, Inc. | 427.94M | 6.06% | 129,562 | - |
| 481 | CRMD | CorMedix Inc. | 426.36M | 2.82% | 2,330,247 | 462.25M |
| 482 | PHAT | Phathom Pharmaceuticals, Inc. | 423.36M | 1.52% | 1,938,585 | 274.88M |
| 483 | EDIT | Editas Medicine, Inc. | 422.35M | 7.00% | 3,722,436 | 49.83M |
| 484 | AVTX | Avalo Therapeutics, Inc. | 420.37M | 4.91% | 2,803,820 | 59.00K |
| 485 | CERS | Cerus Corporation | 418.05M | 2.48% | 2,454,277 | 226.57M |
| 486 | TLRY | Tilray Brands, Inc. | 417.99M | -2.40% | 3,280,629 | 963.10M |
| 487 | CCCC | C4 Therapeutics, Inc. | 413.65M | 1.61% | 3,785,538 | 32.28M |
| 488 | ALT | Altimmune, Inc. | 412.38M | 1.92% | 4,366,988 | 31.00K |
| 489 | CTEV | Claritev Corporation | 409.79M | 5.68% | 731,550 | 1.02B |
| 490 | MOBI | Mobia Medical, Inc. | 408.60M | 9.56% | 178,283 | 51.89M |
| 491 | STLN | Starling Oncology, Inc. | 407.96M | 10.50% | 8,837,656 | 620.45M |
| 492 | RZLT | Rezolute, Inc. | 405.98M | -0.26% | 2,463,031 | - |
| 493 | MPLT | MapLight Therapeutics, Inc. | 404.59M | 5.05% | 458,804 | - |
| 494 | CTNM | Contineum Therapeutics, Inc. | 404.44M | 8.19% | 264,652 | - |
| 495 | PRLD | Prelude Therapeutics Incorporated | 387.26M | 4.44% | 230,958 | 22.42M |
| 496 | FENC | Fennec Pharmaceuticals Inc. | 379.78M | 10.40% | 245,801 | 59.22M |
| 497 | LYEL | Lyell Immunopharma, Inc. | 379.11M | 3.77% | 409,886 | 15.00K |
| 498 | SSII | SS Innovations International, Inc. | 374.72M | -11.37% | 161,514 | 52.40M |
| 499 | AGMB | AgomAb Therapeutics NV | 371.82M | -1.18% | 661,583 | - |
| 500 | DTIL | Precision BioSciences, Inc. | 369.49M | -8.68% | 590,228 | 45.04M |